View in EDS HTML Full Text PDF Full Text

Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.

Saved in:
Bibliographic Details
Title: Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.
Authors: Sherafat NS; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Keshavarz A; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Mardi A; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran., Mohammadiara A; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Aghaei M; Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Aghebati-Maleki L; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Leili_aghebati_maleki@yahoo.com.; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran. Leili_aghebati_maleki@yahoo.com., Mohammadi MH; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Drmohammadi@sbmu.ac.ir.
Source: Clinical and experimental medicine [Clin Exp Med] 2025 Jul 08; Vol. 25 (1), pp. 238. Date of Electronic Publication: 2025 Jul 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40629032
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sherafat+NS%22">Sherafat NS</searchLink>; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.<br /><searchLink fieldCode="AU" term="%22Keshavarz+A%22">Keshavarz A</searchLink>; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Mardi+A%22">Mardi A</searchLink>; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.<br /><searchLink fieldCode="AU" term="%22Mohammadiara+A%22">Mohammadiara A</searchLink>; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Aghaei+M%22">Aghaei M</searchLink>; Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.<br /><searchLink fieldCode="AU" term="%22Aghebati-Maleki+L%22">Aghebati-Maleki L</searchLink>; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Leili_aghebati_maleki@yahoo.com.; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran. Leili_aghebati_maleki@yahoo.com.<br /><searchLink fieldCode="AU" term="%22Mohammadi+MH%22">Mohammadi MH</searchLink>; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Drmohammadi@sbmu.ac.ir.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100973405%22">Clinical and experimental medicine</searchLink> [Clin Exp Med] 2025 Jul 08; Vol. 25 (1), pp. 238. <i>Date of Electronic Publication: </i>2025 Jul 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Italia%22">Springer-Verlag Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>100973405 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1591-9528 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215918890%22">15918890 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40629032
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10238-025-01751-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 238
    Titles:
      – TitleFull: Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sherafat NS
      – PersonEntity:
          Name:
            NameFull: Keshavarz A
      – PersonEntity:
          Name:
            NameFull: Mardi A
      – PersonEntity:
          Name:
            NameFull: Mohammadiara A
      – PersonEntity:
          Name:
            NameFull: Aghaei M
      – PersonEntity:
          Name:
            NameFull: Aghebati-Maleki L
      – PersonEntity:
          Name:
            NameFull: Mohammadi MH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2025 Jul 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1591-9528
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical and experimental medicine
              Type: main
ResultId 1